Mesenchymal stem cells/marrow stromal cells (MSCs) present a promising tool for cell
therapy, and are currently being tested in US FDA-approved clinical trials for myocardial …

Mesenchymal Stem Cells or Marrow Stromal Cells (MSCs) have long been viewed as a
potent tool for regenerative cell therapy. MSCs are easily accessible from both healthy donor …

Transplantation of mesenchymal stem cells (MSCs) into the injured brain may provide
therapeutic benefits. Several models of brain diseases have been examined, including that …

Stem cell-based therapies for neurodegenerative diseases aim at halting clinical
deterioration by regeneration and by providing local support for damaged tissue …

Cellular therapies represent a new frontier in the treatment of neurological disease.
Mesenchymal stem cells (MSCs), which can be harvested from bone marrow, adipose …

Bone marrow-derived mesenchymal stem cells (MSCs) are attractive candidates for use in
regenerative medicine since they are easily accessible and can be readily expanded in vivo …

Mesenchymal stem cells (MSCs) represent a promising source of material for autologous
cell transplantation therapies, in particular, their potential use for the treatment of damaged …

Neurodegenerative disease is a kind of chronic, progressive nervous system disease
characterized by neuron degeneration or apoptosis. Current treatments cannot prevent the …

Mesenchymal stem cells resident in adult bone marrow are best characterized by their
capacity to differentiate into connective tissue cell types such as adipocytes, chondrocytes …

Background: Stem-cell-based therapy is a promising new approach to handling
neurodegenerative diseases. One of the most promising cellular sources is bone-marrow …